Advertisement
ProteinSimple
ProteinSimple

The Nutshell

» evolution, cancer and policy

Daily News Roundup

Most Recent

image: Obesity Drugs in Check

Obesity Drugs in Check

By | April 2, 2012

The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: MIT Students Petition Congress

MIT Students Petition Congress

By | March 27, 2012

Graduate students ask for more federal research support.

2 Comments

image: More Oversight for Omics Tests

More Oversight for Omics Tests

By | March 27, 2012

A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.

0 Comments

image: James Cameron Hits Rock Bottom

James Cameron Hits Rock Bottom

By | March 27, 2012

The movie director-turned-explorer made the 6.8-mile drop to the deepest point on the seafloor, but wasn’t too impressed by what he found.

4 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: My DNA, My Results

My DNA, My Results

By | March 22, 2012

Are donors of biological material privy to research results that stem from their donation?

2 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement